series-b
Stage
3
Investors
About
Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat autoimmune and inflammatory diseases by restoring balance to the immune system.
Explore Sonoma Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.